Feleshia
liked
$Invesco QQQ Trust (QQQ.US)$ $SPDR Dow Jones Industrial Average Trust (DIA.US)$ $SPDR S&P 500 ETF (SPY.US)$ What I have learned during this year is :
You don't always have to buy the dips.
Sometimes doing nothing is best.
ETFs are your friend.
If you are long term, don't worry about the day to day fluctuation up or down.
You don't always have to buy the dips.
Sometimes doing nothing is best.
ETFs are your friend.
If you are long term, don't worry about the day to day fluctuation up or down.
22
Feleshia
liked
What is the downside to copying Nancy Pelosi's trades with shares when she is buying deep ITM calls?
$Alphabet-C (GOOG.US)$ $Salesforce (CRM.US)$ $VanEck Vectors AMT-Free Intermediate Municipal Index ETF (ITM.US)$
On 12/17/2021 Pelosi bought 10 GOOG calls with a strike of $2000 and exp 9/16/2022. On 12/17 it closed at 2856. Right now it's trading at 2,929. Apparently Nancy is the greatest investor of all time. Assuming she maintains her accuracy, what is the downside here of just going all in on GOOG shares?
Same questi...
On 12/17/2021 Pelosi bought 10 GOOG calls with a strike of $2000 and exp 9/16/2022. On 12/17 it closed at 2856. Right now it's trading at 2,929. Apparently Nancy is the greatest investor of all time. Assuming she maintains her accuracy, what is the downside here of just going all in on GOOG shares?
Same questi...
17
Feleshia
liked
$NVIDIA (NVDA.US)$ $E-mini NASDAQ 100 Futures(SEP4) (NQmain.US)$ Nasdaq 100 future is down that’s all tech stocks drop. Under 80% automation trading system, this index is critical factor for Nasdaq up and down unless there is spike news for some stocks.
18
1
Feleshia
liked
Should be a law where congress members can only invest in mutual funds and index funds
Translated
12
Feleshia
liked
11
Feleshia
liked
$Advanced Micro Devices (AMD.US)$ ASUS Teases Next-Gen ROG Flow Z13, Claims It ‘s The ‘World’s Most Powerful Gaming Tablet’
AMD is in preparations to reveal their AMD Ryzen 6000 series, also known as "Rembrandt," which will showcase a Zen3+ as well as RDNA2 microarchitecture, at CES 2022. It is expected that ASUS will reveal the new model during their event that is happening on the same day. There is speculation that since the X13 Flow was equipped with the AMD Ryzen processor, this new device will ...
AMD is in preparations to reveal their AMD Ryzen 6000 series, also known as "Rembrandt," which will showcase a Zen3+ as well as RDNA2 microarchitecture, at CES 2022. It is expected that ASUS will reveal the new model during their event that is happening on the same day. There is speculation that since the X13 Flow was equipped with the AMD Ryzen processor, this new device will ...
13
Feleshia
liked
$NVIDIA (NVDA.US)$ You know it's just retail traders selling because it's the $300 psychological level for them to sell. I mean I guess if they want to buy back at $325 next week, that's up to them.
12
Feleshia
liked
$NVIDIA (NVDA.US)$ Hasn't NVDA stock doubled like every year for the past 3 years? Why would it not do the same thing in 2022?
12
Feleshia
liked
$Advanced Micro Devices (AMD.US)$ $Xilinx (XLNX.US)$
Advanced Micro Devices (NASDAQ:AMD) said its acquisition of Xilinx (NASDAQ:XLNX) is expected to close in the first quarter of 2022 rather than this year as they have not yet secured all approvals. The company said its conversations with regulators continue to progress productively, and it expects to secure all required approvals.
Advanced Micro Devices (NASDAQ:AMD) said its acquisition of Xilinx (NASDAQ:XLNX) is expected to close in the first quarter of 2022 rather than this year as they have not yet secured all approvals. The company said its conversations with regulators continue to progress productively, and it expects to secure all required approvals.
14
Feleshia
liked
$Biogen (BIIB.US)$ $SAMSUNG EL 144 (SSNGY.US)$ The potential deal would mark Samsung Group's largest transaction since 2016, when the company bought U.S. electronics systems maker Harman for $8 billion.
The company's shares have fallen so far this year, dropping more than 30% in the past six months alone, despite the FDA approval of its Alzheimer's drug for marketing and regulatory victory in June.
The company's shares have fallen so far this year, dropping more than 30% in the past six months alone, despite the FDA approval of its Alzheimer's drug for marketing and regulatory victory in June.
11